Metropolitan Life Insurance CO Ionis Pharmaceuticals Inc Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

47 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$29.88 - $37.04 $263,332 - $326,433	-8,813 Closed	0 $0
Q4 2021 Jun 21, 2023	BUY	$25.61 - $35.1 $225,700 - $309,336	8,813 New	8,813 $268,000
Q4 2021 Mar 30, 2023	BUY	$25.61 - $35.1 $3,918 - $5,370	153 Added 1.77%	8,813 $268,000
Q4 2021 Feb 15, 2022	BUY	$25.61 - $35.1 $3,918 - $5,370	153 Added 1.77%	8,813 $268,000
Q3 2021 Jun 21, 2023	BUY	$33.54 - $40.55 $297,835 - $360,084	8,880 New	8,880 $297,000
Q3 2021 Mar 30, 2023	SELL	$33.54 - $40.55 $17,206 - $20,802	-513 Reduced 5.59%	8,660 $290,000
Q3 2021 Nov 15, 2021	SELL	$33.54 - $40.55 $17,206 - $20,802	-513 Reduced 5.59%	8,660 $290,000
Q2 2021 Jun 21, 2023	BUY	$34.54 - $47.25 $316,835 - $433,424	9,173 New	9,173 $365,000
Q2 2021 Mar 30, 2023	BUY	$34.54 - $47.25 $155,499 - $212,719	4,502 Added 96.38%	9,173 $365,000
Q2 2021 Aug 16, 2021	BUY	$34.54 - $47.25 $316,662 - $433,188	9,168 Added 183360.0%	9,173 $366,000
Q1 2021 Jun 26, 2023	BUY	$42.51 - $63.78 $255,697 - $383,636	6,015 New	6,015 $270 Million
Q1 2021 Mar 30, 2023	SELL	$42.51 - $63.78 $63,850 - $95,797	-1,502 Reduced 24.33%	4,671 $210,000
Q1 2021 May 14, 2021	SELL	$42.51 - $63.78 $262,201 - $393,395	-6,168 Reduced 99.92%	5 $210,000
Q4 2020 Jun 22, 2023	BUY	$45.3 - $60.27 $279,636 - $372,046	6,173 New	6,173 $349,000
Q4 2020 Mar 30, 2023	SELL	$45.3 - $60.27 $6,115 - $8,136	-135 Reduced 2.14%	6,173 $349,000
Q4 2020 Feb 16, 2021	SELL	$45.3 - $60.27 $6,115 - $8,136	-135 Reduced 2.14%	6,173 $349,000
Q3 2020 Jun 26, 2023	BUY	$47.45 - $62.95 $299,314 - $397,088	6,308 New	6,308 $299,000
Q3 2020 Mar 30, 2023	SELL	$47.45 - $62.95 $7,022 - $9,316	-148 Reduced 2.29%	6,308 $299,000
Q3 2020 Nov 13, 2020	SELL	$47.45 - $62.95 $7,022 - $9,316	-148 Reduced 2.29%	6,308 $299,000
Q2 2020 Jun 26, 2023	BUY	$46.85 - $61.05 $302,463 - $394,138	6,456 New	6,456 $380,000
Q2 2020 Mar 30, 2023	SELL	$46.85 - $61.05 $117,921 - $153,662	-2,517 Reduced 28.05%	6,456 $380,000
Q2 2020 Aug 14, 2020	SELL	$46.85 - $61.05 $117,921 - $153,662	-2,517 Reduced 28.05%	6,456 $381,000
Q1 2020 Jul 12, 2023	BUY	$41.6 - $63.4 $373,276 - $568,888	8,973 New	8,973 $424,000
Q1 2020 Mar 30, 2023	SELL	$41.6 - $63.4 $11,772 - $17,942	-283 Reduced 3.06%	8,973 $424,000
Q1 2020 May 15, 2020	SELL	$41.6 - $63.4 $11,772 - $17,942	-283 Reduced 3.06%	8,973 $424,000
Q4 2019 Jul 12, 2023	BUY	$53.85 - $65.27 $498,435 - $604,139	9,256 New	9,256 $559,000
Q4 2019 Mar 30, 2023	SELL	$53.85 - $65.27 $9,262 - $11,226	-172 Reduced 1.82%	9,256 $559,000
Q4 2019 Feb 14, 2020	SELL	$53.85 - $65.27 $9,262 - $11,226	-172 Reduced 1.82%	9,256 $559,000
Q3 2019 Jul 12, 2023	BUY	$59.06 - $72.15 $556,817 - $680,230	9,428 New	9,428 $564,000
Q3 2019 Mar 30, 2023	BUY	$59.06 - $72.15 $13,465 - $16,450	228 Added 2.48%	9,428 $564,000
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $13,465 - $16,450	228 Added 2.48%	9,428 $565,000
Q2 2019 Jul 12, 2023	BUY	$62.09 - $86.14 $571,228 - $792,488	9,200 New	9,200 $591,000
Q2 2019 Mar 30, 2023	SELL	$62.09 - $86.14 $13,225 - $18,347	-213 Reduced 2.26%	9,200 $591,000
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $13,225 - $18,347	-213 Reduced 2.26%	9,200 $591,000
Q1 2019 Jul 13, 2023	BUY	$52.92 - $81.17 $498,135 - $764,053	9,413 New	9,413 $764,000
Q1 2019 Mar 30, 2023	BUY	$52.92 - $81.17 $498,135 - $764,053	9,413 New	9,413 $764,000
Q1 2019 May 16, 2019	BUY	$52.92 - $81.17 $436,695 - $669,814	8,252 Added 710.77%	9,413 $764,000
Q1 2019 May 15, 2019	SELL	$52.92 - $81.17 $447,121 - $685,805	-8,449 Reduced 87.92%	1,161 $37,000
Q4 2018 Jul 13, 2023	BUY	$43.37 - $59.54 $416,785 - $572,179	9,610 New	9,610 $519,000
Q4 2018 Feb 14, 2019	SELL	$43.37 - $59.54 $1,344 - $1,845	-31 Reduced 0.32%	9,610 $520,000
Q3 2018 Jul 13, 2023	BUY	$42.88 - $53.7 $413,406 - $517,721	9,641 New	9,641 $497 Million
Q3 2018 Nov 14, 2018	SELL	$42.88 - $53.7 $8,190 - $10,256	-191 Reduced 1.94%	9,641 $497,000
Q2 2018 Aug 15, 2018	BUY	$40.53 - $50.7 $24,520 - $30,673	605 Added 6.56%	9,832 $0
Q1 2018 May 15, 2018	BUY	$44.08 - $55.05 $132 - $165	3 Added 0.03%	9,227 $0
Q4 2017 Feb 15, 2018	SELL	$50.3 - $64.39 $4,426 - $5,666	-88 Reduced 0.95%	9,224 $464,000
Q3 2017 Nov 14, 2017	BUY	$45.56 - $59.57 $21,641 - $28,295	475 Added 5.38%	9,312 $472,000
Q2 2017 Aug 14, 2017	BUY	N/A	8,837	8,837 $450,000

Others Institutions Holding IONS

# of Institutions

402

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

Vanguard Group Inc Valley Forge, PA

15.1M
Shares

$512 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

14.2M
Shares

$482 Million
0.34% of portfolio
Black Rock Inc. New York, NY

10.3M
Shares

$351 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

8.74M
Shares

$297 Million
0.06% of portfolio
Bellevue Group Ag Kuesnacht, V8

7.87M
Shares

$268 Million
5.32% of portfolio

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $4.83B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account